INTOUCH DECEMBER 2017 / JANUARY 2018
Which doctor is all shook up as he celebrates the launch of Code ELVIS—a code to streamline treatment for patients during a specific kind of stroke. To find out, keep reading. (Photo by Yuri Markarov, Medical Media Centre)
ELVIS is in the building By Geoff Koehler
An ischemic stroke occurs when a blood vessel is blocked and the brain’s blood supply is cut off. Every minute that blood can’t reach the brain, 1.9 million neurons are lost. Without timely treatment, this brain clot can cause severe disability and even death. For nearly 20 years, a clot-busting drug called tissue-type plasminogen activator, or tPA, has been the only therapy with proven clinical benefit for patients experiencing an ischemic stroke. When the blockage is in a large blood vessel, however, research has shown that rapidly removing the clot Printed on 100 per cent recycled paper
can lead to better outcomes than tPA alone. “To implement these findings, stroke at St. Michael’s was all shook up so that we coined a new code, ELVIS, to get the patients who would benefit from this intervention into the neuroangiography suite faster,” said Dr. Tom Marotta, an interventional neuroradiologist with the Medical Imaging Department. “Now there’s a little less conversation that needs to happen before patients can get their clot removed.” Code ELVIS, which stands for Endovascular Large Vessel Ischemic Stroke, was launched Dec. 4 to reduce
process times and improve patient outcomes. Under Code ELVIS, patients with a large vessel ischemic stroke who are coming to St. Michael’s in an ambulance are registered as patients even before arriving at the Emergency Department. When paramedics arrive at the hospital with a stroke patient, the patient will stay on the ambulance stretcher through the ED, up to the CT scanner for assessment, and then to the neuroangigraphy suite if the blockage meets the criteria. Continued on page 2 DECEMBER 2017 / JANUARY 2018 | IN TOUCH | 1